评估目前和新兴的JAK抑制剂用于脱发区域:叙述性审查
Katherine Sanchez1,2, Hanna Englander1,3, Lana Salloum1,4
1Department of Dermatology, Brigham and Women's Hospital, 221 Longwood Avenue, Boston, MA, 02115, USA.
Dermatology and therapy
|August 12, 2025
概括
简氏激酶 (JAK) 抑制剂是治疗白发症 (AA) 的有效新疗法,这是一种自身免疫性脱发症. 在临床试验中,已批准的JAK抑制剂如巴里西丁尼布,里特利西丁尼布和德鲁克索利丁尼布显示显著的头发再生.
科学领域:
- 皮肤病学和免疫学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 脱发症 (alopecia areata) 是一种自身免疫性疾病,导致无痕的脱发,影响全球人口的2%.
- 现有的AA治疗方法的疗效有限,并存在潜在的长期安全问题,需要新的治疗策略.
研究的目的:
- 审查和综合目前的临床证据和关于用于治疗白发症的Janus激酶 (JAK) 抑制剂的试验数据.
- 为医疗保健专业人员和研究人员提供关于用于AA管理的JAK抑制剂治疗的最新资源.
主要方法:
- 审查最近的临床进展和关键试验数据,FDA批准的JAK抑制剂 (巴里西提尼布,里特利西提尼布,德鲁克索利提尼布).
- 包括关于非标签 JAK 抑制剂使用 (托法西提尼布,鲁克索利提尼布) 的研究,证明在有限的环境中有效.
主要成果:
- 巴里西提尼布显示了持久的疗效,35-40%的患者在36周内实现了显著的头发再生 (脱发症的严重程度工具得分≤20).
- 里特利西提尼布和德鲁克索利提尼布也表现出显著的疗效,分别有23%和31%的患者在24周内达到SALT得分≤20.
- 非标签的JAK抑制剂在AA治疗的初步研究中显示出有前途.
结论:
- 雅努斯酶 (JAK) 抑制剂代表了有希望的,针对性治疗选择,治疗白发症,解决潜在的免疫机制.
- 最近的FDA批准和临床试验数据支持特定的JAK抑制剂在促进大量头发再生方面的有效性.
- 持续的研究和证据综合对于优化JAK抑制剂在AA管理中的使用和改善患者结果至关重要.
相关概念视频
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
Clinical Applications of Epidermal Stem Cells
2.8K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.8K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Autoimmune Disorders
672
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
672


